Skip to main content
Top

Diabetologia

Issue Special Issue 3/2001

Content (16 Articles)

Increasing incidence of childhood-onset Type I diabetes in 3 Baltic countries and Finland 1983–1998

T. Podar, A. Solntsev, M. Karvonen, Z. Padaiga, G. Brigis, B. Urbonaite, M. Viik-Kajander, A. Reunanen, J. Tuomilehto

Comparative incidence of Type I diabetes in children aged under 15 years from South Asian and White or Other ethnic backgrounds in Leicestershire, UK, 1989 to 1998

N. T. Raymond, J. R. Jones, P. G. F. Swift, M. J. Davies, I. G. Lawrence, P. G. McNally, M. L. Burden, R. Gregory, J. L. Botha, A. C. Burden

The large increase in incidence of Type I diabetes mellitus in Poland

A. Krętowski, I. Kowalska, J. Peczyñska, M. Urban, A. Green, I. Kinalska

Low frequency of HLA DRB1*03 – DQB1*02 and DQB1*0302 haplotypes in Romania is consistent with the country's low incidence of Type I diabetes

C. Ionescu-Tîrgoviste, C. Guja, M. Herr, F. Cucca, K. Welsh, M. Bunce, S. Marshall, J. A. Todd

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine